De-escalation of breast cancer treatment for Her2-positive breast cancer

被引：0
|
作者：
Swarnkar, Parinita [1 ]
Mokbel, Lara [2 ]
Mokbel, Kefah [1 ]
机构：
[1] London Breast Inst, Princess Grace Hosp, London W1U 5NY, England
[2] Latymer Upper Sch, London, England
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2022年 / 196卷 / 01期
关键词：
D O I：
10.1007/s10549-022-06737-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：243 / 244
页数：2
相关论文
共 50 条
  • [1] De-escalation of breast cancer treatment for Her2-positive breast cancer
    Parinita Swarnkar
    Lara Mokbel
    Kefah Mokbel
    Breast Cancer Research and Treatment, 2022, 196 : 243 - 244
  • [2] Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies
    Krawczyk, Natalia
    Fehm, Tanja
    Ruckhaeberle, Eugen
    Brus, Laura
    Kopperschmidt, Valeria
    Rody, Achim
    Hanker, Lars
    Banys-Paluchowski, Maggie
    CANCERS, 2022, 14 (12)
  • [3] Safe de-escalation of chemotherapy in HER2-positive early breast cancer
    Earl, Helena M.
    LANCET, 2024, 403 (10437): : 1606 - 1607
  • [4] De-escalation in low-risk, HER2-positive breast cancer
    Geuna, Elena
    Curigliano, Giuseppe
    Montemurro, Filippo
    LANCET ONCOLOGY, 2023, 24 (03): : 200 - 201
  • [5] HER2-Positive Early Breast Cancer: Time for Ultimate De-Escalation?
    Tauber, Nikolas
    Cirkel, Christoph
    Claussen, Anna
    Fick, Franziska
    Kontomanolis, Emmanuel
    Krawczyk, Natalia
    Rody, Achim
    Banys-Paluchowski, Maggie
    CANCERS, 2024, 16 (06)
  • [6] De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance
    Veeraraghavan, Jamunarani
    De Angelis, Carmine
    Reis-Filho, Jorge S.
    Pascual, Tomas
    Prat, Aleix
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Schiff, Rachel
    BREAST, 2017, 34 : S19 - S26
  • [7] De-escalation of neoadjuvant therapy for HER2-positive early breast cancer: an overview
    Werutsky, Gustavo
    Rosa, Mahira Lopes
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (04) : 1352 - 1357
  • [8] Escalation and de-escalation in HER2 positive early breast cancer
    Dieci, Maria Vittoria
    Vernaci, Grazia
    Guarneri, Valentina
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (01) : 35 - 42
  • [9] A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer
    Waks, Adrienne G.
    Desai, Neelam V.
    Li, Tianyu
    Poorvu, Philip D.
    Partridge, Ann H.
    Sinclair, Natalie
    Spring, Laura M.
    Faggen, Meredith
    Constantine, Michael
    Metzger, Otto
    Alberti, Jillian
    Deane, Julia
    Rosenberg, Shoshana M.
    Frank, Elizabeth
    Tolaney, Sara M.
    Krop, Ian E.
    Tung, Nadine M.
    Tayob, Nabihah
    King, Tari A.
    Mittendorf, Elizabeth A.
    Winer, Eric P.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [10] A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer
    Adrienne G. Waks
    Neelam V. Desai
    Tianyu Li
    Philip D. Poorvu
    Ann H. Partridge
    Natalie Sinclair
    Laura M. Spring
    Meredith Faggen
    Michael Constantine
    Otto Metzger
    Jillian Alberti
    Julia Deane
    Shoshana M. Rosenberg
    Elizabeth Frank
    Sara M. Tolaney
    Ian E. Krop
    Nadine M. Tung
    Nabihah Tayob
    Tari A. King
    Elizabeth A. Mittendorf
    Eric P. Winer
    npj Breast Cancer, 8
12345